• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    TD SYNNEX Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    4/8/25 4:02:43 PM ET
    $SNX
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $SNX alert in real time by email
    snx-20250402
    0001177394false11/3000011773942025-04-022025-04-0200011773942024-12-012025-11-30

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant To Section 13 or 15(d) of the
    Securities Exchange Act of 1934

    Date of Report (Date of Earliest Event Reported): April 2, 2025
    TD SYNNEX CORPORATION
    (Exact name of registrant as specified in its charter)
    Delaware001-3189294-2703333
    (State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)


    44201 Nobel Drive, Fremont, California
    (Address of principal executive offices)

    94538    
    (Zip Code)
                                
    (510) 668-3400
    (Registrant’s telephone number, including area code)

    N/A
    (Former name or former address, if changed since last report.)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common stock, par value $0.001 per shareSNXThe New York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).     
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





    Item 5.03
    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
    At the Annual Meeting of Stockholders of TD SYNNEX Corporation (the “Company”) held on April 2, 2025, the stockholders approved amendments to the Company’s Restated Certificate of Incorporation, as amended, regarding the removal of supermajority voting requirements, removal of obsolete provisions, and limitation of liability of certain officers. On April 7, 2025, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Restated Certificate of Incorporation, as amended (“Charter Amendment”) to adopt such amendments, which became effective upon filing. The foregoing description of the Charter Amendment is qualified in its entirety by reference to the full text of the Charter Amendment, a copy of which is attached as Exhibit 3(i) to this report and incorporated herein by reference.

    Item 5.07
    Submission of Matters to a Vote of Security Holders.
    As described above, the Company held its Annual Meeting of Stockholders on April 2, 2025, at which the following occurred:

    Proposal 1: Election of ten directors to hold office until the 2026 Annual Meeting of Stockholders:
    ELECTION OF
    DIRECTOR
    FOR
    WITHHELD
    BROKER NON-VOTES
    Ann Vezina
    75,327,732580,2742,788,212
    Patrick Zammit
    75,735,395172,6132,788,210
    Kathleen Crusco
    75,716,891191,1152,788,212
    Ting Herh72,037,9943,870,0112,788,213
    Richard Hume
    75,674,895233,1122,788,211
    Kenneth Lamneck
    75,727,809180,1982,788,211
    Nayaki Nayyar
    69,615,2506,292,7552,788,213
    Dennis Polk
    74,312,8441,595,1632,788,211
    Claude Pumilia
    75,465,704442,3032,788,211
    Merline Saintil
    71,955,2203,952,7842,788,214

    Proposal 2: The advisory vote to approve the compensation of the Company’s named executive officers was as follows:

    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    65,319,38910,399,952188,6622,788,215

    Proposal 3: The vote to ratify the selection of KPMG LLP as the Company’s independent registered public accountants by the Audit Committee of the Board of Directors of the Company (the “Board of Directors”) was as follows:
    FOR
    AGAINST
    ABSTAIN
    77,737,327628,698330,193

    Proposal 4: The vote to adopt the amendment to the Company’s Restated Certificate of Incorporation, as amended, to eliminate the supermajority voting requirements was as follows:

    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    75,004,803793,233109,9692,788,213

    Proposal 5: The vote to adopt the amendment to the Company’s Restated Certificate of Incorporation, as amended, to remove obsolete provisions was as follows:

    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    75,130,145716,545123,7102,725,818




    Proposal 6: The vote to adopt the amendment to the Company’s Restated Certificate of Incorporation, as amended, to limit the liability of certain officers of the Company was as follows:
    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    64,735,07611,000,734172,1932,788,215

    Proposal 7: The vote to approve the Board of Directors’ proposal to create a stockholder right to call a special meeting of stockholders was as follows:
    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    65,709,3765,894,8564,303,7772,788,209

    Proposal 8: The vote on a stockholder proposal regarding shareholder ability to call for a special shareholder meeting was as follows:
    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    25,991,51849,703,189213,2932,788,218

    Item 9.01    Financial Statements and Exhibits.

    (d) Exhibits.
    Exhibit No.Description of Document
    3(i)
    Certificate of Amendment to Restated Certificate of Incorporation of TD SYNNEX Corporation, as amended.
    104Cover Page Interactive Data File (embedded within the Inline XBRL document).






    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    Date: April 8, 2025TD SYNNEX CORPORATION
    By:
    /s/ David Vetter
    David Vetter
    Chief Legal Officer and Corporate Secretary
        








    Get the next $SNX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SNX

    DatePrice TargetRatingAnalyst
    6/11/2025$145.00Overweight
    Morgan Stanley
    3/20/2025$138.00 → $156.00Outperform
    Barrington Research
    7/15/2024$135.00 → $140.00Sector Perform → Outperform
    RBC Capital Mkts
    4/16/2024$115.00 → $145.00Neutral → Buy
    UBS
    1/8/2024$112.00 → $113.00Overweight → Neutral
    JP Morgan
    11/22/2023$105.00Neutral
    UBS
    5/1/2023$101.00Buy
    Goldman
    2/15/2023$109.00Equal Weight
    Barclays
    More analyst ratings